CASI Announces Renewed Distribution Agreement
CASI had a great day in the market on Friday after announcing a distribution agreement renewal. The agreement is an exclusive one, under which, China Resources Pharmaceutical Commercial Group International Trading will continue to be the sole distributor for the sale of EVOMELA for Injection in China.
Find out more about CASI stock here.
The post CASI Pharmaceuticals (CASI) Stock Climbs On Distribution Agreement News originally appeared at CNA Finance.